Free Cash Flow

With a massively oversubscribed bond sale and upgraded credit ratings, Italian API giant FIS solidifies its finances to expand in a booming pharma market.

A new report reveals a looming crisis: rising healthcare costs will consume more than 100% of Social Security benefits for future generations of retirees.

With major drug approvals on the horizon, Nuvalent's leadership will detail its strategy for its next-gen cancer therapies at an influential investor summit.

The investment giant posted a record $129 billion in annual fundraising, but a slight miss on quarterly earnings sent its stock tumbling.

AEIS declares its quarterly dividend, signaling deep financial stability and strategic confidence fueled by explosive growth in key tech sectors.

Barrick Mining unveils a massive dividend hike and a new cash-return policy, but a surprising market dip raises questions about its future outlook.

Despite currency woes and a tough market, the access solutions giant posts record sales and income, fueled by strategic acquisitions and innovation.

Kenmare Resources unveils its upgraded Moma Mine, a critical global titanium source, as it pivots from heavy spending to cash generation.

Volvo Cars' Q4 profits fell, but a tough cost-cutting plan boosted cash flow, setting the stage for its critical electric vehicle push in a tough market.

Forgent Power Solutions prices its IPO at $27 a share, targeting a massive valuation fueled by intense demand from data centers and grid modernization.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?

Canfor Pulp and Canfor Corp prepare for a critical joint earnings call on March 6 after a year of steep losses and severe market headwinds.

Forum Energy Technologies has extended its $250M credit facility to 2031, a move that strengthens its balance sheet and fuels its 'FET 2030' growth plans.

The insurance giant beat adjusted earnings estimates on strong operational performance, even as derivative losses weighed on its reported GAAP revenue.

DHI Group announces a $10M stock buyback, a bold move showing faith in its strategy as it navigates a complex, AI-driven tech recruitment landscape.

With its lead drug MOLBREEVI under FDA review, Savara's upcoming investor talks are a critical test of its path from clinical trials to market.

IUOE Local 150 backs Speaker Welch for State Central Committeeperson, signaling a major power play in Illinois Democratic politics post-Danny Davis.

The frozen potato giant appoints an AB InBev veteran as Executive Chair and a new CFO, signaling a major push for global expansion and shareholder value.

The AI boom runs on powerful chips that generate immense heat. Discover how the once-overlooked HVAC industry is now a critical infrastructure investment.

With a fresh capital infusion extending its runway into 2027, GRI Bio pushes ahead with promising clinical data for its IPF and autoimmune disease pipeline.